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OBJECTIVES We examined the prevalence and severity of renal artery stenosis (RAS) in patients
undergoing cardiac catheterization who were deemed at risk for RAS based on clinical or
laboratory criteria for study entry, but who had not previously been suspected of having RAS.
BACKGROUND The diagnosis of atherosclerotic RAS remains problematic because its clinical manifestations
are nonspecific.
METHODS Consecutive patients undergoing non-emergent cardiac catheterization at a single institution
during a 12-month period were evaluated using standardized clinical, laboratory, and
angiographic criteria. Patients exhibiting at least one of four predefined selection criteria
(severe hypertension, unexplained renal dysfunction, acute pulmonary edema with hyperten-
sion, or severe atherosclerosis) were prospectively registered and underwent coincident
diagnostic renal angiography.
RESULTS Renal angiography was performed in 851 patients and was diagnostic in 837. Angiographi-
cally evident renal atherosclerosis was present in 39% of the population, with RAS 50% in
120 (14.3%) and severe stenosis (70%) in 61 (7.3%). Severe stenosis was present in 48 (7%)
patients with severe atherosclerosis, 38 (16%) with renal dysfunction, 25 (9%) with
hypertension, and 2 (22%) with acute pulmonary edema with hypertension. The prevalence
was higher in those exhibiting multiple selection criteria. In a multivariate model, severe RAS
was associated with age, female gender, reduced creatinine clearance, increased systolic blood
pressure, and peripheral or carotid artery disease.
CONCLUSIONS In a population at risk of, but not previously suspected of having RAS, severe RAS is
associated with simple and readily determined clinical and laboratory patient characteristics.
These data facilitate focused application of diagnostic renal angiography. (J Am Coll
Cardiol 2004;43:1606–13) © 2004 by the American College of Cardiology Foundationc
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nhe clinical diagnosis of atherosclerotic renal artery stenosis
RAS) remains problematic. In contrast to myocardial
schemia, the pathophysiologic manifestations of RAS (hy-
ertension, renal dysfunction, and acute left ventricular
LV] failure) are nonspecific and often attributed to other
rocesses. This dilemma has hindered both the clinical
etection of RAS in individuals at risk and the determina-
ion of RAS prevalence in populations at risk.
See page 1614
Contrast angiography is a standard criterion for RAS; it
s readily performed in combination with coronary angiog-
aphy. A correlation between coronary disease burden and
he prevalence of RAS has already been established, but
ssociations between patient demographic characteristics,
oronary disease burden, extracoronary atherosclerosis, pu-
ative manifestations of RAS, and the prevalence of RAS
ave not been prospectively and rigorously examined.
From the Department of Medicine, Divisions of *Cardiology and †Nephrology,
niversity of British Columbia, Vancouver; ‡Centre for Health Evaluation and
utcome Sciences, Vancouver; and the §Vancouver Hospital, Vancouver, Canada.
his study was funded internally by the Vancouver Hospital Interventional Cardiol-
gy Clinical Trials trust.
Manuscript received June 27, 2003; revised manuscript received November 7, 2003,cccepted November 13, 2003.To determine the overall prevalence of RAS in a cohort
onsidered at risk, but who had not previously been sus-
ected of having RAS, we performed renal angiography in
51 patients undergoing clinically indicated non-emergent
oronary angiography over a 12-month period in a single
nstitution. Subjects were required to meet at least one of
he predefined selection criteria: 1) severe atherosclerosis; 2)
evere or resistant hypertension; 3) unexplained renal dys-
unction; or 4) acute pulmonary edema presumed due to
iastolic LV dysfunction. We then examined in detail, as
ell as modeled, the associations between the presence of
ngiographically demonstrated RAS and baseline clinical,
aboratory, and angiographic variables.
ETHODS
creening and data collection. Between June 2001 and
ay 2002 (inclusive), we screened all patients undergoing
on-emergent diagnostic cardiac catheterization at Vancou-
er Hospital and evaluated them for study inclusion accord-
ng to predetermined criteria. Before catheterization, a
rotocol-based clinical examination was used to determine
emographics, cardiac history, indications for cardiac cath-
terization, atherogenic risk factors, features of extracoro-
ary vascular disease, and related comorbidities. We re-
orded current antihypertensive and cardiovascular drug
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May 5, 2004:1606–13 Renal Artery Stenosisherapy and normalized doses of agents affecting blood
ressure (BP) using World Heath Organization (WHO)-
tandardized daily dose equivalents (1). We obtained non-
nvasive BP readings during usual therapy, before catheter-
zation and after at least 5 min of rest, using a previously
alidated automated manometer (VSM MedTech Ltd.,
ancouver, BC, Canada) employing multiple readings av-
raged over 5 min (2,3).
nclusion criteria. We categorized all patients according to
he presence or absence of each of four selection criteria
etermined a priori (Table 1). The criteria were developed
o identify patients with putative pathophysiologic manifes-
ations of RAS (hypertension, renal dysfunction, or acute
ulmonary edema) or advanced atherosclerosis in other
ascular territories. Patients meeting at least one selection
riterion before knowledge of the coronary anatomy were
nvited to participate and asked to provide written consent
efore their cardiac catheterization procedure. Patients not
able 1. Selection Criteria for Renal Artery Angiography
Category Subcategory Definition
ypertension
Resistant Systolic BP 140 or diastolic BP 90 mm Hg
while on 2 drug classes at 2 defined daily
doses
Severe Systolic BP 180 or diastolic BP 110 mm Hg
regardless of drug therapy
idney dysfunction
Unexplained C-G CrCl 50 ml/min without clearly
established cause
ACEI-ARB induced Documented acute renal dysfunction attributable
to ACEI or ARB therapy
cute pulmonary
edema
Radiographic grade III and no other
recognized cause (e.g., EF 40%, AMI,
severe valvular disease) and associated with
acute hypertension (160/100 mm Hg) or
chronic hypertension
evere atherosclerosis
(Abdominal aortic
or lower extremity
artery disease)
Causing stenosis 50% diameter; documented
atherosclerotic aneurysm; Previous peripheral
or aortic surgery; or Intermittent claudication
with corroborative physical examination
erebrovascular disease Ischemic or arterial embolic stroke; carotid bruit;
causing stenosis 50%; or previous carotid
revascularization
evere coronary disease Three territories with 60% stenosis; previous
revascularization of 3 territories; or left main
coronary 50% stenosis
CEI  angiotensin-converting enzyme inhibitor; AMI  acute myocardial infarc-
ion; ARB  angiotensin receptor blocker; BP  blood pressure; CrCl  creatinine
Abbreviations and Acronyms
BP  blood pressure
CAD  coronary artery disease
CrCl  creatinine clearance
GFR  glomerular filtration rate
LV  left ventricular
PRKD  procedure-related kidney dysfunction
RAS  renal artery stenosisPlearance; C-G  Cockcroft-Gault; EF  ejection fraction.eeting a selection criterion before catheterization were
sked to provide written consent to participate if cardiac
atheterization demonstrated qualifying severe coronary
therosclerosis. We excluded patients for any of the follow-
ng reasons: renal replacement therapy, known or suspected
cute renal failure, history of contrast nephropathy, hemo-
ynamic instability, physician preference, or refusal or
nability to provide informed consent. Baseline serum cre-
tinine was measured before the procedure; estimated cre-
tinine clearance (CrCl) was calculated using the
ockcroft-Gault formula; and the glomerular filtration rate
GFR) was estimated using the Modification of Diet in
enal Disease formula (4). Renal dysfunction (as an inclu-
ion criterion) was based on Cockcroft-Gault CrCl 50
l/min or GFR 60 ml/min. Patients qualifying for
nclusion on the basis of renal dysfunction alone were
xcluded if a well-documented cause of renal dysfunction
xisted. The study was approved by the Institutional Review
oard of the University of British Columbia.
enal artery angiography. Participating patients under-
ent either selective or nonselective renal angiography
efore completion of their cardiac catheterization proce-
ure. Selective angiography was encouraged and generally
mployed a right Judkins coronary catheter with hand
njection of 4 to 8 ml of contrast agent (ioversol; Optiray,
allinckrodt, Pointe-Claire, Quebec, Canada) in each
ain and accessory renal artery and with supplementary
emiselective injections if needed. Nonselective angiogra-
hy, when utilized, was performed by powered injection of
20 ml Optiray over 1 s through a pigtail catheter posi-
ioned at the level of the L1 vertebral body in the postero-
nterior projection. All images were recorded digitally at 30
rames/s. Digital subtraction was reserved for cases with
oor visualization of the renal artery due to overlying gas or
tructures.
Each operator categorically graded main and proximal
enal arteries as normal or abnormal (any roughening or
tenosis consistent with atherosclerosis) and further catego-
ized abnormal arteries according to visually estimated
iameter stenosis severity (50% [mild], 50% to 70%
significant], 70% to 99% [severe], or 100% [totally
ccluded]) and according to stenosis location (aorto-ostial
r other). The consensus of at least two experienced
ngiographers was required in cases where stenosis severity
as initially uncertain. When uncertainty remained and
onsensus could not be achieved, patients were excluded.
afety. Administration of periprocedural intravenous fluids
r N-acetyl cysteine was left to the discretion of the
esponsible physician. Repeat serum creatinine was obtained
ve to seven days after enrollment and evaluated centrally.
e predefined procedure-related kidney dysfunction
PRKD) as an increase in serum creatinine of 0.5 mg/dl
44.2 mol/l). Patients exhibiting PRKD had repeat serum
reatinine determinations every two weeks until return to
alues within 0.5 mg/dl of baseline. We predefined chronic
RKD as dysfunction lasting at least 12 weeks. Require-
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Renal Artery Stenosis May 5, 2004:1606–13ent for renal replacement therapy within 12 weeks of
nrollment was recorded and categorized as temporary or
rolonged. For redundancy, we linked the data set to the
ritish Columbia Renal Agency (a central registry of all
ialysis patients in the Province of British Columbia)
atabase to capture any incidence of dialysis within 12
eeks of enrollment.
ata management and statistical analysis. Registry data
n all participating patients were entered in a central study
atabase. Coronary anatomy and LV ejection fraction were
btained by linkage to the British Columbia Cardiac Reg-
stries (5).
Descriptive statistics are presented as the mean value 
D or frequency (%). The clinical characteristics of patients
ere compared using analysis of variance for continuous
ariables and the chi-square test for categorical variables.
ifferences in lateral distribution of renal artery abnormal-
ties were tested using Bowker’s test of symmetry (6). A
alue of p  0.05 for two-sided univariate tests was
onsidered statistically significant. The logistic regression
odel was used to investigate the multivariate associations
etween severe RAS (70%) and patient characteristics.
he variables included in the multivariate analysis were
atient age and gender, diabetes, smoking, weight, GFR,
ystolic BP, diastolic BP, resistant hypertension, unex-
able 2. Results of Renal Angiography Categorized by Severity
f Renal Artery Stenosis
Frequency
Left Renal Artery
Normal <50% 50%–70% 70%–99% 100%
Right Renal
Artery
Normal 528 84 17 12 3
50% 50 55 18 6 1
50%–70% 14 6 4 3 0
70%–99% 11 4 7 10 2
100% 2 0 0 0 0
able 3. Prevalence and Severity of Renal Artery Stenosis Accord
Selection Criteria
Total
(N  837)
evere atherosclerosis 651 (78%)
esistant/severe HTN 264 (32%)
enal impairment 232 (28%)
ulmonary edema 9 (1%)
TN components
Resistant hypertension 245 (29%)
Severe hypertension 19 (2.3%)
evere atherosclerosis components
Abdominal aortic/lower extremity disease 101 (12%)
Carotid disease 97 (12%)
Severe CAD 572 (68%)
LMCA disease 89 (11%)
ercentages under “total” column refer to denominator of N  837 and do not sum
normal” to 70% are calculated based on the number in the corresponding “total”CAD  coronary artery disease; HTN  hypertension; LMCA  left main coronarylained renal impairment, abdominal aortic/lower extremity
isease, carotid artery disease, severe coronary artery disease
CAD), and acute pulmonary edema. The model fit was
ested using the Hosmer-Lemeshow goodness-of-fit test
7). The backward elimination method was used to select
he variables for the model. The area under the receiver-
perating characteristics (ROC) curve for the selected
odel was determined by the trapezoidal rule.
ESULTS
opulation. During the screening period, 2,428 patients
ere evaluated. Of these patients, 47% (n  1,149) met at
east one selection criterion, of whom 298 met exclusion
riteria because of non-renovascular kidney dysfunction (n
14), renal replacement therapy (n  16), known or
uspected acute kidney failure (n 5), pulmonary edema on
urrent examination (n  5), hemodynamic instability (n 
), patient refusal (n 109), or physician refusal (n 144).
enal angiography was performed in 851 but was judged to
e nondiagnostic in 14 (1.6%). The remaining 837 patients
onstituted the study cohort. Selective renal angiography
lone was employed in 471 (56%), aortography in 314
38%), and both techniques in 52 (6%) patients. Acute
RKD was observed in 17 patients (2%), but was transient
n all but one. No patient required renal replacement
herapy within 12 weeks of enrollment. No renovascular,
ortic, or other catheter-related complications attributable
o renal angiography were observed.
revalence of RAS in selected cohort. Table 2 shows the
revalence of each category of RAS in the study cohort,
tratified by the left or right renal artery. Angiographically
vident renal artery atherosclerosis was common (n  309
36.9%]). A total of 120 (14.3%) patients had stenosis 50%
n at least one proximal renal artery and 61 (7.3%) had severe
tenosis 70%. Severe bilateral stenosis (70% in both arter-
es), however, was infrequent (n  12 [1.4%]), and occlusions
o Individual Selection Criteria
Renal Artery Angiography
ormal
 528)
<50%
(n  189)
50%–<70%
(n  59)
>70%
(n  61)
8 (63%) 146 (22%) 49 (8%) 48 (7%)
4 (54%) 74 (28%) 21 (8%) 25 (9%)
2 (53%) 53 (23%) 19 (8%) 38 (16%)
1 (11%) 4 (44%) 2 (22%) 2 (22%)
6 (55%) 69 (28%) 20 (8%) 20 (8%)
8 (42%) 5 (26%) 1 (5%) 5 (26%)
8 (48%) 22 (22%) 16 (16%) 15 (15%)
2 (43%) 29 (30%) 9 (9%) 17 (18%)
2 (64%) 124 (22%) 43 (8%) 33 (6%)
3 (60%) 19 (21%) 11 (12%) 6 (7%)
0% because patients may satisfy multiple criteria. Percentages under columns from
n.ing t
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May 5, 2004:1606–13 Renal Artery Stenosisere rare (n  8 [1%]). Significantly more abnormal renal
rteries were observed on the left side (p  0.028).
election criteria and RAS results. Table 3 shows the
roportion of patients meeting each selection criterion,
ogether with each criterion’s corresponding distribution of
everity of RAS (the compound atherosclerosis/
ypertension criteria are also shown according to their
omponents). Severe atherosclerosis, predominantly due to
he presence of severe coronary atherosclerosis, was the most
requent selection criterion and was present in 78% of
atients (n  651). Resistant or severe hypertension was
resent in 264 (32%) patients, unexplained kidney dysfunc-
ion in 232 (28%), and acute pulmonary edema in 9 (1%).
nly 7 (2.2%) of 232 patients with unexplained kidney
ysfunction were included on the basis of a documented
istory of acute renal dysfunction caused by angiotensin-
onverting enzyme inhibitors or angiotensin receptor block-
rs. Kidney dysfunction and pulmonary edema criteria were
able 4. Prevalence and Severity of Renal Artery Stenosis Accord
Variables
Total
(N  837)
Normal
(n  528)
ge (yrs) 67.0  9.9 65.4  10.2 6
60 207 (25%) 168 (81%)
60–69 286 (34%) 177 (61%)
70 344 (41%) 183 (53%)
emale gender 211 (25%) 113 (53%)
iabetes 264 (32%) 170 (64%)
eight (kg) 79.4  15.5 80.6  15.5 7
moking
Never 361 (43%) 229 (63%)
Former 390 (47%) 244 (62%)
Current 86 (10%) 55 (64%)
ystolic BP 136  24 133  22
iastolic BP 75  12 75  12
rCl (C-G) 72  29 77  29
Comparisons according to specified variable. Percentages under “total” column refer
he frequency of each corresponding renal artery stenosis (RAS) severity category wi
he “total” column. Other data are presented as the mean value  SD.
BP  blood pressure; C-G  Cockcroft-Gault; CrCl  creatinine clearance.
able 5. Prevalence and Severity of Renal Artery Stenosis Accord
Variable Total Normal
VEF (n) 719 458
30 33 (5%) 21 (63%)
30–50 215 (30%) 141 (66%)
50 471 (65%) 296 (63%)
AD extent (n) 792 501
All 50 stenosis 73 (9%) 51 (70%)
Single-vessel 74 (9%) 39 (52%)
Two-vessel 133 (17%) 81 (61%)
Three-vessel 386 (49%) 253 (66%)
LMCA 79 (10%) 49 (62%)
Severe LMCA 47 (6%) 28 (60%)
Comparisons according to the specified variable. Percentages under “total” column re
o the frequency of each corresponding renal artery stenosis severity category within t
olumn.LVEF  left ventricular ejection fraction; other abbreviations as in Table 3.ssociated the highest prevalence of severe RAS (16% and
2%, respectively). However, these criteria identified fewer
ases of severe stenosis than did the more commonly
atisfied criterion of severe atherosclerosis.
Patients satisfying more than one selection criterion were
ommon: 226 (27%) fulfilled two criteria and 46 (5%)
ulfilled three or four criteria. Patients satisfying multiple
nclusion criteria were significantly more likely to exhibit
enal artery atherosclerosis and stenosis than those satisfying
nly one criteria. Requiring two or more selection criteria to
ualify for renal angiography would have identified 41
66%) of 61 cases of severe RAS from a cohort of 272
atients (15% prevalence).
linical and laboratory variables. Tables 4 and 5 provide
pecific demographic, clinical, laboratory, and cardiac cath-
terization characteristics of the study cohort in aggregate
nd according to the findings at renal artery angiography.
nivariate demographic and clinical variables associated
o Patient Characteristics
Severity of RAS
p Value*
0%
189)
50%–<70%
(n  59)
>70%
(n  61)
9.0 69.2  8.6 73.2  6.5 0.0001
4%) 7 (3%) 2 (1%) 0.001
2%) 25 (9%) 19 (7%)
7%) 27 (8%) 40 (12%)
4%) 20 (9%) 27 (13%) 0.001
1%) 22 (8%) 17 (6%) 0.591
15.7 77.2  14.9 72.7  14.0 0.0008
0.083
3%) 18 (5%) 29 (8%)
0%) 35 (9%) 31 (8%)
8%) 6 (6%) 1 (1%)
24 140  24 146  31 0.0001
12 73  11 77  14 0.4483
27 64  25 50  22 0.0001
ominator of N  837. Percentages under columns from “normal” to 70% refer to
e cohort, defined by the variable, and are calculated based on the number shown in
o Cardiac Catheterization Findings
enal Artery Angiography
p Value*50% 50%–<70% >70%
163 49 49 0.875
(21%) 2 (6%) 3 (9%)
(23%) 15 (7%) 10 (5%)
(23%) 32 (7%) 36 (8%)
177 57 57 0.041
(22%) 1 (1%) 5 (7%)
(31%) 6 (8%) 6 (8%)
(20%) 6 (5%) 19 (14%)
(21%) 34 (9%) 19 (5%)
(24%) 5 (6%) 6 (8%)
(25%) 5 (10%) 2 (4%)
denominator of N  837. Percentages under columns from “normal” to 70% refer
ort, defined by the variable, and are calculated based on the number shown in “total”ing t
<5
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Renal Artery Stenosis May 5, 2004:1606–13ith 70% RAS include age (73.2 vs. 66.5 years, p 
.0001), female gender (13% vs. 6%, p 0.001), lower body
eight (72.7 vs. 79.9 kg, p 0.0005), preprocedural systolic
P (146.4 vs. 135.4 mm Hg, p  0.0084), and reduced
rCl (52.5 vs. 68.0 ml/min, p  0.0001). No significant
elationship was observed with diabetes, cigarette smoking
istory, diastolic BP, or LV ejection fraction.
Patients age 60 years accounted for 25% of the selected
opulation, but only 2 (3%) of 61 cases of severe RAS and
(8%) of 120 cases of significant stenosis (Fig. 1). The
revalence of significant and severe RAS among women was
igure 2. Patterns of advanced atherosclerosis detected in men (bars with
hick diagonal lines) versus women (bars with thin diagonal lines).
emale gender remained independently associated with renal artery steno-
is after adjustment for other patient characteristics. See text for discussion.
igure 1. Prevalence of renal artery stenosis (RAS) by age. Renal artery
tenosis was infrequent in patients under age 60 years, despite the
equirement that all patients meet predefined selection criteria for renal
ngiography. Severe RAS was present in 0 of 37 patients age 40 years, 1
1.3%) of 75 patients age 40 to 49 years, 5 (2.4%) of 210 age 50 to 59 years,
2 (7.7%) of 287 age 60 to 69 years, 35 (15.8%) of 221 age 70 to 79 years,
nd 20 (7.0%) of 142 age 80 years or older. Age remained independently
ssociated with RAS after adjustment for other patient characteristics.
egrees of RAS stenosis: 70% (solid black bars); 50% to 70% (bars
ith thick diagonal lines); and normal or 50% (bars with thin diagonal
ines).pp  0.001. CAD  coronary artery disease; Ext  extremity.pproximately double that observed in men (significant:
2% vs. 12%, p  0.001; severe: 13% vs. 6%, p  0.001).
his pattern was observed despite a similar prevalence of
ther peripheral or carotid artery disease and a significantly
ower prevalence of severe coronary disease (50% vs. 75%, p
0.001) (Fig. 2). The relationship between severe RAS
nd coronary disease burden, as expressed by vessel count,
as complex and indirect (Table 5). The highest prevalence
f severe RAS was observed with intermediate coronary
isease burden.
Multivariate modeling showed age, female gender, clin-
cally apparent carotid and peripheral arterial disease, kidney
ysfunction, and systolic hypertension to be factors inde-
endently associated with severe RAS (Table 6). The area
nder the ROC curve for this model is 0.799. The Hosmer-
emeshow goodness-of-fit statistic for the model is Cˆ 
0.02, with p  0.26, indicating no evidence of a lack of fit
n the selected model.
ISCUSSION
his study demonstrates the prevalence of angiographic
AS in a cohort of patients undergoing coronary angiog-
aphy, who exhibited one or more risk factor criteria for
AS but who were not previously suspected of having RAS.
ther investigators have also described unexpected RAS in
atients undergoing cardiac catheterization, but they used
bdominal aortography exclusively and did not employ
respecified criteria to select individuals at risk from all
atients undergoing cardiac catheterization. In a seminal
tudy, Harding et al. (8) found an 11% prevalence of RAS
defined as stenosis 50%) in an unselected cohort of 1,235
atients. Subsequent reports (9,10) derived from small series
f clinically (rather than systematically) selected cohorts
bserved prevalence rates of 11% and 18%, respectively.
hese reports focused on the relationship between coronary
isease burden and RAS prevalence but were limited by the
bsence of protocol-based patient selection and character-
zation.
The present study reflects a contemporary cardiac cathe-
erization population and differs methodologically from
revious reports in several important ways. First, we per-
ormed renal angiography only in patients manifesting a
able 6. Multivariate Associations With Severe Renal Artery
tenosis
Variable OR 95% CI p Value
ge (per 10 yrs) 1.721 1.185–2.497 0.0043
ender (female) 1.907 1.069–3.403 0.0288
FR (per 5 ml/min) 0.861 0.792–0.935 0.0004
BP (per 5 mm Hg) 1.082 1.024–1.142 0.0049
bdominal aortic or lower
extremity disease
2.063 1.043–4.079 0.0374
arotid artery disease 3.128 1.618–6.047 0.0007
I  confidence interval; GFR  glomerula filtration rate; OR  odds ratio; SBP 
ystolic blood pressure.otential consequence of RAS (using predefined objective
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May 5, 2004:1606–13 Renal Artery Stenosisriteria of severe or resistant hypertension, unexplained
idney dysfunction, or pulmonary edema with preserved
ystolic function) or in whom objective evidence of severe
therosclerosis existed. This approach identified a preva-
ence of RAS higher than that observed in unselected
ardiac catheterization-based studies. Second, rigorous
creening for predefined enrollment criteria drove a detailed
rotocol-based and standardized collection of clinical and
aboratory patient characteristics. The data generated pro-
ide a robust basis for modeling associations. Third, we
ncouraged the use of selective renal angiography, rather
han aortography, and employed both techniques if the
nitial images were not diagnostic. The need for use of both
echniques in 6% of registered patients speaks to the
iagnostic superiority of this complementary approach over
ither technique alone. Fourth, we systematically screened
or impairment of kidney function attributable to the
rocedures at regular intervals after the procedure. Finally,
ecognizing that no universally accepted angiographic defi-
ition for RAS exists, we distinguished between 50% and
70% stenosis (albeit semiquantitatively) and conservatively
pplied our modeling of associations only to stenoses70%.
Our study extends and quantifies the relationships be-
ween RAS and extrarenal atherosclerosis burden. In our
ohort, coronary disease burden was not observed to have an
mportant association with RAS. Patients with two-vessel
oronary disease (who, by protocol, required a noncoronary
riterion for inclusion) displayed a 14% prevalence of severe
AS. Those with more advanced three-vessel or left main
oronary disease (who most often qualified for inclusion on
he basis of coronary disease burden alone) displayed an
AS prevalence of 8% (Table 4). We also found the
revalence of both renal atherosclerosis and significant or
evere RAS was substantially higher in subgroups defined by
eripheral or carotid disease than in groups defined by
evere CAD. Renal artery stenosis remained strongly asso-
iated with clinically evident atherosclerosis in noncoronary
erritories, particularly the carotid arteries, after adjustment
or all other known factors, including coronary disease
urden.
The associations we observed between RAS and carotid
r peripheral vascular disease may entirely be due to covari-
nce and simply reflect a large total body plaque burden.
owever, there is accumulating evidence that the physio-
ogic consequences of RAS may themselves drive athero-
clerosis (11). For instance, disturbed intrarenal hemody-
amics leading to inappropriate activation of the renin-
ngiotensin system with consequent long-term, excess
timulation of angiotensin type 1 receptors is hypothesized
o have a pivotal pathogenetic role, and the converse
long-term antagonism of the renin-angiotensin system by
ngiotensin-converting enzyme inhibition) has been shown
o reduce cardiovascular events and death (12). Further-
ore, ischemic renal dysfunction itself can result not only in
ypertension but also in other atherogenic disturbances,
ncluding increased oxidative stress, dyslipidemia, reduced uxcretion of homocysteine, abnormal phosphate/calcium
etabolism, and anemia. In this light, it is possible that the
ssociations previously noted could partly reflect a causal
elationship between RAS and advanced generalized ath-
rosclerosis.
Older age was strongly and independently associated with
AS, implying delayed development or slower progression
f atherosclerosis in renal compared with coronary and other
eripheral vascular territories. Despite meeting enrollment
riteria, we detected significant RAS infrequently among
ndividuals under 60 years of age. This observation has
mportant practical implications for cardiac catheterization-
ased RAS screening.
The relationship between RAS and secondary hyperten-
ion mediated through inappropriate renin-angiotensin sys-
em activation has long been established (13). Although
evere hypertension was associated with a 26% prevalence of
evere RAS and an adjusted odds ratio of 4, it was an
nfrequent finding and therefore of limited potential clinical
tility. The association between RAS and systolic BP,
xpressed as a continuous variable, holds greater promise for
nclusion in formulae to determine the pretest likelihood of
AS. Notably, the association between RAS and diastolic
P did not persist in the multivariate model. Our data
annot distinguish whether this reflects abnormal vascular
mpedance typical of patients predisposed to RAS or im-
edance characteristics arising due to RAS-driven vascular
ypertrophy, calcification, and sclerosis.
The strong association with female gender extends pre-
ious observations (14). Persistence of female gender in the
ultivariate model after adjustment for age and other
actors is intriguing and remains unexplained. Moreover,
ur data suggest a gender-specific distribution of atheroscle-
osis characterized by greater coronary disease burden
mong men, greater RAS burden among women, and
imilar rates of clinically evident carotid and peripheral
rterial disease in both genders. Heart failure with preserved
ystolic function has also recently been shown to be strongly
ssociated with female gender (15). The pathogenetic basis
or this association, however, remains enigmatic. The higher
revalence of RAS in women compared with men, which
e observed, with a consequently greater burden of systolic
ypertension, ischemic renal dysfunction, LV and vascular
ypertrophy, and sodium retention could account, at least
artly, for this observation.
Atherosclerotic RAS as a cause of kidney dysfunction and
nd-stage kidney disease is being increasingly recognized.
ecent reports state that RAS is the most common poten-
ially reversible disorder leading to renal replacement ther-
py (16,17). However, the degree to which RAS accounts
or renal dysfunction in broadly defined cardiac populations
s unknown. We observed a 24% prevalence of RAS
50%) in the 232 patients who met the enrollment
riterion of unexplained kidney dysfunction. Furthermore,
alculated CrCl demonstrated an independent and contin-
ous relation to the likelihood of detecting RAS when
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Renal Artery Stenosis May 5, 2004:1606–13xamined in the entire cohort (including patients with
ormal renal function, mild dysfunction [CrCl 50 ml/
in], or dysfunction attributed to known causes). Although
his strong association does not necessarily imply causation,
rospective studies of patients with identified RAS could be
esigned to measure the impact of RAS progression on
rogression of kidney disease. At a minimum, it appears
hat clinicians should consider RAS when kidney dysfunc-
ion and CAD coexist.
In addition to the substantial burden of end-stage disease
f the kidney associated or attributable to RAS, a large body
f evidence now links renal function to cardiovascular
ortality in patients with cardiac disease (18–20). Further-
ore, the severity of RAS has been shown to correlate to
ortality in long-term follow-up of a cardiac catheterization
opulation (11). Thus, well-designed, large-scale, random-
zed trials comparing current medical management alone to
evascularization of the kidney need to be conducted to
efine the most appropriate therapy for RAS in cardiac
opulations. Key questions include whether kidney revas-
ularization can preserve or improve kidney dysfunction,
elay the need for renal replacement therapy, or perhaps,
ost importantly, reduce cardiovascular events and mortal-
ty. Methodologic limitations of existing trials have
rompted the development of American Heart Association
uidelines for reporting of renal artery revascularization in
linical trials (21). Efficient identification of patients with
AS will be needed to conduct such definitive trials. The
ndings reported herein could enable the identification of
atients with a significant pretest likelihood of RAS based
n easily captured clinical and laboratory data.
tudy limitations. The observations and associations made
n our analysis apply with certainty only to patients under-
oing cardiac catheterization who met one or more of our
redefined selection criteria. Although broad and clinically
ntuitive, these criteria apply to only one-half of all patients
ndergoing non-emergent cardiac catheterization at our
nstitution. We did not employ quantitative or independent
nalysis of the severity of RAS. Quantitative analysis of
orto-ostial lesions is, in any event, problematic. We used
ategorical grading of severity, intended to minimize poten-
ial discrepancies and deemphasize small gradations of
everity. Furthermore, the use of a single-plane projection
or assessment of stenosis severity may fail to identify
ccentric stenoses. Our measures of prevalence are therefore
ikely to be conservative. It is possible our method of safety
urveillance failed to document new kidney impairment due
o atheroembolism, which occurred after the five- to seven-
ay follow-up after the procedure. Because renal replace-
ent therapy in British Columbia is registered centrally, we
re confident that no patient in our cohort underwent
ialysis within 12 weeks of enrollment. Finally, our analysis
id not attempt to correlate abnormalities in kidney size or
plit renal function with RAS.
onclusions. This study characterizes, in detail, patients atisk of RAS in whom scheduled cardiac catheterizationfforded an opportunity to determine whether RAS was
resent by angiographic criteria. We found the overall
revalence of significant and severe angiographic RAS was
ubstantial in this cohort and described independent asso-
iations between severe RAS and readily identifiable clinical
nd laboratory variables. We also found selective renal
ngiography coincident with cardiac catheterization to be
afe in an otherwise high-risk group with prevalent periph-
ral vascular atherosclerosis and preexisting kidney dysfunc-
ion when performed by experienced cardiac angiographers.
ong-term follow-up of this cohort to determine the
ignificance of RAS, with respect to specific heart and
idney disease outcomes, is the focus of future research.
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